• 1
    Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C. and Ho, D. D., Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol. 1994. 68: 46504655.
  • 2
    Harrer, E., Harrer, T., Buchbinder, S., Mann, D. L., Feinberg, M., Yilma, T., Johnson, R. P. and Walker, B. D., HIV-1-specific cytotoxic T lymphocyte response in healthy, long-term nonprogressing seropositive persons. AIDS Res. Hum. Retroviruses 1994. 10: S7778.
  • 3
    Rinaldo, C., Huang, X. L., Fan, Z. F., Ding, M., Beltz, L., Logar, A., Panicali, D. et al., High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol. 1995. 69: 58385842.
  • 4
    Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P. et al., Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 1998. 279: 21032106.
  • 5
    Thananchai, H., Makadzange, T., Maenaka, K., Kuroki, K., Peng, Y., Conlon, C., Rowland-Jones, S. and Dong, T., Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8+ T cells and NK cells. AIDS 2009. 23: 189193.
  • 6
    Neisig, A., Melief, C. J. and Neefjes, J., Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J. Immunol. 1998. 160: 171179.
  • 7
    McCutcheon, J. A., Gumperz, J., Smith, K. D., Lutz, C. T. and Parham, P., Low HLA-C expression at cell surfaces correlates with increased turnover of heavy chain mRNA. J. Exp. Med. 1995. 181: 20852095.
  • 8
    Wilson, C. C., Kalams, S. A., Wilkes, B. M., Ruhl, D. J., Gao, F., Hahn, B. H., Hanson, I. C. et al., Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition. J. Virol. 1997. 71: 12561264.
  • 9
    Rauch, A., Laird, R., McKinnon, E., Telenti, A., Furrer, H., Weber, R., Smillie, D. and Gaudieri, S., Influence of inhibitory killer immunoglobulin-like receptors and their HLA-C ligands on resolving hepatitis C virus infection. Tissue Antigens 2007. 69: 237240.
  • 10
    Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K. et al., A whole-genome association study of major determinants for host control of HIV-1. Science 2007. 317: 944947.
  • 11
    Johnson, R. P., Trocha, A., Buchanan, T. M. and Walker, B. D., Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone. J. Virol. 1993. 67: 438445.
  • 12
    Marsh, S. G. E., Parham, P. and Barber, L., The HLA Facts Book, Academic Press, London 2000.
  • 13
    Matthews, P. C., Prendergast, A., Leslie, A., Crawford, H., Payne, R., Rousseau, C., Rolland, M. et al., Central role of reverting mutations in HLA associations with human immunodeficiency virus set point. J. Virol. 2008. 82: 85488559.
  • 14
    Appay, V., Dunbar, P. R., Callan, M., Klenerman, P., Gillespie, G. M., Papagno, L., Ogg, G. S. et al., Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 2002. 8: 379385.
  • 15
    Cao, Y., Qin, L., Zhang, L., Safrit, J. and Ho, D. D., Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection. N. Engl. J. Med. 1995. 332: 201208.
  • 16
    Carmichael, A., Jin, X., Sissons, P. and Borysiewicz, L., Quantitative analysis of the human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T lymphocyte (CTL) response at different stages of HIV-1 infection: differential CTL responses to HIV-1 and Epstein-Barr virus in late disease. J. Exp. Med. 1993. 177: 249256.
  • 17
    Cohen, G. B., Gandhi, R. T., Davis, D. M., Mandelboim, O., Chen, B. K., Strominger, J. L. and Baltimore, D., The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 1999. 10: 661671.
  • 18
    Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D. and Baltimore, D., HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 1998. 391: 397401.
  • 19
    Goulder, P. J., Bunce, M., Luzzi, G., Phillips, R. E. and McMichael, A. J., Potential underestimation of HLA-C-restricted cytotoxic T-lymphocyte responses. AIDS 1997. 11: 18841886.
  • 20
    Adnan, S., Balamurugan, A., Trocha, A., Bennett, M. S., Ng, H. L., Ali, A., Brander, C. and Yang, O. O., Nef interference with HIV-1-specific CTL antiviral activity is epitope specific. Blood 2006. 108: 34143419.
  • 21
    Appay, V., Nixon, D. F., Donahoe, S. M., Gillespie, G. M., Dong, T., King, A., Ogg, G. S. et al., HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 2000. 192: 6375.
  • 22
    Trimble, L. A., Kam, L. W., Friedman, R. S., Xu, Z. and Lieberman, J., CD3zeta and CD28 down-modulation on CD8 T cells during viral infection. Blood 2000. 96: 10211029.
  • 23
    Ehl, S., Hombach, J., Aichele, P., Rulicke, T., Odermatt, B., Hengartner, H., Zinkernagel, R. and Pircher, H., Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J. Exp. Med. 1998. 187: 763–774.
  • 24
    Bunce, M., O'Neill, C. M., Barnardo, M. C., Krausa, P., Browning, M. J., Morris, P. J. and Welsh, K. I., Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995. 46: 355367.
  • 25
    Zemmour, J., Little, A. M., Schendel, D. J. and Parham, P., The HLA-A,B “negative” mutant cell line C1R expresses a novel HLA-B35 allele, which also has a point mutation in the translation initiation codon. J. Immunol. 1992. 148: 19411948.
  • 26
    Fan, Q. R., Garboczi, D. N., Winter, C. C., Wagtmann, N., Long, E. O. and Wiley, D. C., Direct binding of a soluble natural killer cell inhibitory receptor to a soluble human leukocyte antigen-Cw4 class I major histocompatibility complex molecule. Proc. Natl. Acad. Sci. USA 1996. 93: 71787183.
  • 27
    Lalvani, A., Dong, T., Ogg, G., Patham, A. A., Newell, H., Hill, A. V., McMichael, A. J. and Rowland-Jones, S., Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors. J. Immunol. Methods 1997. 210: 6577.